Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
Price:
8.35 CNY
1.33%
Updated:
May 6, 2024
Qianjiang Yongan Pharmaceutical Co Ltd
Operating Income
|
Qianjiang Yongan Pharmaceutical Co Ltd
Operating Income Peer Comparison
Comparables:
H
3692
600436
600276
000538
C
300765
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
|
Operating Income
¥23.3m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-5%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥3.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥3.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Operating Income
¥787.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
See Also
What is Qianjiang Yongan Pharmaceutical Co Ltd's Operating Income?
Operating Income
23.3m
CNY
23.3m
CNY
Based on the financial report for Sep 30, 2023, Qianjiang Yongan Pharmaceutical Co Ltd's Operating Income amounts to 23.3m CNY.
What is Qianjiang Yongan Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-5%
-5%
Over the last year, the Operating Income growth was -86%. The average annual Operating Income growth rates for Qianjiang Yongan Pharmaceutical Co Ltd have been -47% over the past three years , -34% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
